share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：诺和诺德-股票回购计划
美股SEC公告 ·  08/12 09:50
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading global healthcare company, has announced the initiation of a share repurchase program on August 7, 2024, as part of a larger 12-month buyback plan set to conclude on February 6, 2025. The current program, which follows the Safe Harbour Rules, involves the repurchase of B shares amounting to DKK 2.4 billion and will run until November 4, 2024. Since the start of the program, Novo Nordisk has bought back 130,250 B shares for a total of DKK 112,401,277. These transactions are separate from the company's incentive programs, which have seen a net transfer of 23,030 B shares. As a result, Novo Nordisk now holds 12,540,136 B shares as treasury shares, representing 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000 A and B shares. Novo Nordisk's stock is traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the initiation of a share repurchase program on August 7, 2024, as part of a larger 12-month buyback plan set to conclude on February 6, 2025. The current program, which follows the Safe Harbour Rules, involves the repurchase of B shares amounting to DKK 2.4 billion and will run until November 4, 2024. Since the start of the program, Novo Nordisk has bought back 130,250 B shares for a total of DKK 112,401,277. These transactions are separate from the company's incentive programs, which have seen a net transfer of 23,030 B shares. As a result, Novo Nordisk now holds 12,540,136 B shares as treasury shares, representing 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000 A and B shares. Novo Nordisk's stock is traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球领先的医疗保健公司诺和诺德已于2024年8月7日宣布启动股份回购计划，该计划为期12个月，计划在2025年2月6日结束。当前符合Safe Harbour Rules的计划涉及回购DKK 24亿的b股份，将在2024年11月4日前持续运行。自计划开始以来，诺和诺德已经回购了1302500亿股，总价值为DKK 112,401,277。这些交易与公司的激励计划是分开的，激励计划已经净转让了230300亿股。因此，诺和诺德现在持有125401360亿股作为财务股份，占持股总数的0.3％。公司的股票总数（包括财务股份）为44.65亿股A和B股。诺和诺德的股票在纳斯达克哥本哈根上交易，其ADR在纽约证券交易所上市。
全球领先的医疗保健公司诺和诺德已于2024年8月7日宣布启动股份回购计划，该计划为期12个月，计划在2025年2月6日结束。当前符合Safe Harbour Rules的计划涉及回购DKK 24亿的b股份，将在2024年11月4日前持续运行。自计划开始以来，诺和诺德已经回购了1302500亿股，总价值为DKK 112,401,277。这些交易与公司的激励计划是分开的，激励计划已经净转让了230300亿股。因此，诺和诺德现在持有125401360亿股作为财务股份，占持股总数的0.3％。公司的股票总数（包括财务股份）为44.65亿股A和B股。诺和诺德的股票在纳斯达克哥本哈根上交易，其ADR在纽约证券交易所上市。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息